BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7270495)

  • 21. Preliminary study on plateletpheresis with the CS-3000 blood cell separator using a single phlebotomy technique.
    Steenssens L; Verbeelen D; Verbruggen R; Van den Broeck M; Jonckheer M; Van Camp B
    Int J Artif Organs; 1984 Jul; 7(4):231-4. PubMed ID: 6490195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Febrile reactions after platelet transfusion: the effect of single versus multiple donors.
    Chambers LA; Kruskall MS; Pacini DG; Donovan LM
    Transfusion; 1990; 30(3):219-21. PubMed ID: 1967118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
    Patidar GK; Sharma RR; Marwaha N
    Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A technique to reduce lymphocyte contamination of plateletapheresis products collected with a centrifugal blood cell separator.
    Mintz PD; Cullis HM; Pearson TH
    Transfusion; 1987; 27(2):159-61. PubMed ID: 3824472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Collection of peripheral blood mononuclear cells as a byproduct of plateletpheresis with two different blood cell separators.
    Hogge DE; Lee CY; Benny WB; Sutherland HJ
    J Clin Apher; 1992; 7(4):208-12. PubMed ID: 1299659
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet collection and transfusion using the fenwal CS-3000 cell separator.
    Katz AJ; Genco PV; Blumberg N; Snyder EL; Camp B; Morse EE
    Transfusion; 1981; 21(5):560-3. PubMed ID: 7292585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase in platelet count is not affected by the platelet yield of single donor pheresed platelets.
    Moser DW; Mackley AB; Hays J; Paul DA
    J Pediatr Hematol Oncol; 2007 May; 29(5):315-8. PubMed ID: 17483709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
    Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
    Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous-flow techniques for platelet concentrate collection: a step toward standardization and yield predictability.
    Hester JP; Kellogg RM; Mulzet AP; Freireich EJ
    J Clin Apher; 1985; 2(3):224-30. PubMed ID: 4030710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy.
    De Clippel D; Baeten M; Torfs A; Emonds MP; Feys HB; Compernolle V; Vandekerckhove P
    Transfusion; 2014 Dec; 54(12):3036-42. PubMed ID: 24863861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of plateletapheresis with two continuous-flow cell separators using identical donors.
    Mintz PD
    Transfusion; 1985; 25(4):330-3. PubMed ID: 4024230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Strategies to recruit plateletpheresis donors from a registry of HLA-typed, unrelated, bone marrow donors.
    Bolgiano DC; Smith S; Slichter SJ
    Transfusion; 1993 Aug; 33(8):675-8. PubMed ID: 8342236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paired crossover study of two plateletpheresis systems concerning platelet product quality and donor comfort.
    Flesch BK; Adamzik I; Steppat D; Miller J; Carstensen L; Schapke M; Davey J
    Transfusion; 2010 Apr; 50(4):894-901. PubMed ID: 19951314
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of plateletpheresis on the Fenwal CS-3000 on donor platelet counts.
    Kalish RI; Chambers LA; Linden JV
    J Clin Apher; 1987; 3(4):230-4. PubMed ID: 3680195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
    Tondon R; Pandey P; Chaudhry R
    J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of platelets prepared by the Haemonetics Model 30 and multiunit bag plateletpheresis.
    Daly PA; Schiffer CA; Aisner J; Wiernik PH
    Transfusion; 1979; 19(6):778-81. PubMed ID: 524435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statewide support of thrombocytopenic patients with ABO matched single donor platelets.
    Reiss RF; Katz AJ
    Transfusion; 1976; 16(4):312-20. PubMed ID: 951726
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Automated plateletpheresis does not cause an increase in platelet activation in volunteer donors.
    Karadoğan I; Undar L
    Ther Apher; 1997 May; 1(2):174-7. PubMed ID: 10225766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo efficacy of shipped HLA-matched platelets.
    Haddad SA; Lichtiger B; Klein HG
    Transfusion; 2006 Aug; 46(8):1306-10. PubMed ID: 16934064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.